Replies to post #502073 on Anavex Life Sciences Corp (AVXL)

[Hoskuld]

Nor is it a requirement for the FDA.

[Guzzi62]

Mr P3 knew that already, I bet.

Always bending the narrative.

[sab63090]

boi568

Believe it or not, I was surprised that ADL was mentioned again...

Especially, since the EMA doesn't even use it!

Things seem to suggest that we might hear something before November 14th, maybe through the grape line?

We are at a significant "spot" on the chart....EVERY important indicator is pointing up to me......maybe I should just shut up!

[rx7171]

The recently approved monoclonal antibodies had CDR-SB as their primary end point.
CDR-SB measures both cognitive and functional improvement so that Blarcamsine did not reach statistical significance in ADL but did in CDR-SB 🤷‍♂️

Blarcasine’s CDR-SB data is much better so if it had been the sole primary end point the issue of the “missed” ADL data at 48 weeks would not be used by shorts to undermine its probability of approval.

[Investor2014]

Too all who replied - you know well that regardless of all your great points, my post is accurate and meant to correct the post replied to.